CuI and CuII complexes with phosphine derivatives of fluoroquinolone antibiotics - A comparative study on the cytotoxic mode of action

J Inorg Biochem. 2018 Apr:181:1-10. doi: 10.1016/j.jinorgbio.2018.01.008. Epub 2018 Jan 9.

Abstract

In this paper, we present a comparative study on the cytotoxic mode of action of copper(I) and copper(II) complexes with phosphine derivatives of fluoroquinolone antibiotics (ciprofloxacin HCp and norfloxacin HNr). The in vitro cytotoxic activity of four new compounds was tested against two selected cancer cell lines. All complexes exhibited much better cytotoxicity against both cell lines than unmodified fluoroquinolone antibiotics, their phosphines (PCp, PNr), chalcogenide derivatives (oxides: OPCp, OPNr; sulfides: SPCp, SPNr and selenides: SePCp, SePNr) and previously described by us complexes with phosphines derived from different fluoroquinolones: lomefloxacin (HLm) and sparfloxacin (HSf) as well as cisplatin. Apoptosis, observed at a great predominance, was induced by all studied complexes. Importantly, it was concluded that coordination compounds with Cu(I) ion ([CuI-PNr] and [CuI-PCp]) were much more active than those with Cu(II) ion ([OPNr-CuII], [OPCp-CuII]), even though the highest efficacy to produce reactive oxygen species, participating in overall cytotoxicity, was proved for copper(II) complexes among all studied compounds. Herein, we discuss not only results obtained for copper(I)/(II) complexes with phosphines derived from HNr and HCp but we also compare them to previously described data for complexes with HLm and HSf derivatives. This is the first insight into a structure-activity relationship of copper complexes with phosphine derivatives of fluoroquinolone antibiotics.

Keywords: Apoptosis; Copper complexes; Fluoroquinolones; ROS production.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma / drug therapy*
  • Adenocarcinoma / metabolism
  • Adenocarcinoma / pathology
  • Adenocarcinoma of Lung
  • Animals
  • Anti-Bacterial Agents / chemistry
  • Anti-Bacterial Agents / pharmacology
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology*
  • Apoptosis / drug effects
  • Carcinoma / drug therapy
  • Carcinoma / metabolism
  • Carcinoma / pathology
  • Cell Line, Tumor
  • Cell Survival / drug effects
  • Chelating Agents / chemistry
  • Chelating Agents / pharmacology
  • Ciprofloxacin / analogs & derivatives*
  • Ciprofloxacin / chemistry
  • Ciprofloxacin / pharmacology
  • Colonic Neoplasms / drug therapy*
  • Colonic Neoplasms / metabolism
  • Colonic Neoplasms / pathology
  • Coordination Complexes / chemistry
  • Coordination Complexes / pharmacology
  • Copper / chemistry
  • Copper / pharmacology*
  • Electrochemical Techniques
  • Humans
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / metabolism
  • Lung Neoplasms / pathology
  • Mice
  • Molecular Structure
  • Norfloxacin / analogs & derivatives*
  • Norfloxacin / chemistry
  • Norfloxacin / pharmacology
  • Phosphines / chemistry
  • Phosphines / pharmacology*
  • Reactive Oxygen Species / agonists
  • Reactive Oxygen Species / metabolism
  • Structure-Activity Relationship

Substances

  • Anti-Bacterial Agents
  • Antineoplastic Agents
  • Chelating Agents
  • Coordination Complexes
  • Phosphines
  • Reactive Oxygen Species
  • Ciprofloxacin
  • Copper
  • Norfloxacin